KEGG   PATHWAY: tge04934
Entry
tge04934                    Pathway                                
Name
Cushing syndrome - Theropithecus gelada (gelada)
Description
Cushing syndrome (CS) is a rare disorder resulting from prolonged exposure to excess glucocorticoids via exogenous and endogenous sources. The typical clinical features of CS are related to hypercortisolism and include accumulation of central fat, moon facies, neuromuscular weakness, osteoporosis or bone fractures, metabolic complications, and mood changes. Traditionally, endogenous CS is classified as adrenocorticotropic hormone (ACTH)-dependent (about 80%) or ACTH- independent (about 20%). Among ACTH-dependent forms, pituitary corticotroph adenoma (Cushing's disease) is most common. Most pituitary tumors are sporadic, resulting from monoclonal expansion of a single mutated cell. Recently recurrent activating somatic driver mutations in the ubiquitin-specific protease 8 gene (USP8) were identified in almost half of corticotroph adenoma. Germline mutations in MEN1 (encoding menin), AIP (encoding aryl-hydrocarbon receptor-interacting protein), PRKAR1A (encoding cAMP-dependent protein kinase type I alpha regulatory subunit) and CDKN1B (encoding cyclin-dependent kinase inhibitor 1B; also known as p27 Kip1) have been identified in familial forms of pituitary adenomas. However, the frequency of familial pituitary adenomas is less than 5% in patients with pituitary adenomas. Among ACTH-independent CS, adrenal adenoma is most common. Rare adrenal causes of CS include primary bilateral macronodular adrenal hyperplasia (BMAH) or primary pigmented nodular adrenocortical disease (PPNAD).
Class
Human Diseases; Endocrine and metabolic disease
Pathway map
tge04934  Cushing syndrome
tge04934

Organism
Theropithecus gelada (gelada) [GN:tge]
Gene
112630655  CRH; corticoliberin [KO:K05256]
112609410  CRHR1; corticotropin-releasing factor receptor 1 isoform X1 [KO:K04578]
112620033  CRHR2; corticotropin-releasing factor receptor 2 isoform X1 [KO:K04579]
112632630  neuroendocrine secretory protein 55 [KO:K04632]
112632629  GNAS; guanine nucleotide-binding protein G(s) subunit alpha isoforms XLas isoform X1 [KO:K04632]
112620936  ADCY1; adenylate cyclase type 1 isoform X1 [KO:K08041] [EC:4.6.1.1]
112625956  ADCY2; adenylate cyclase type 2 [KO:K08042] [EC:4.6.1.1]
112604540  ADCY3; adenylate cyclase type 3 isoform X1 [KO:K08043] [EC:4.6.1.1]
112629482  ADCY4; adenylate cyclase type 4 [KO:K08044] [EC:4.6.1.1]
112618524  ADCY5; adenylate cyclase type 5 [KO:K08045] [EC:4.6.1.1]
112635149  ADCY6; adenylate cyclase type 6 [KO:K08046] [EC:4.6.1.1]
112613998  ADCY7; adenylate cyclase type 7 isoform X1 [KO:K08047] [EC:4.6.1.1]
112630332  ADCY8; adenylate cyclase type 8 isoform X1 [KO:K08048] [EC:4.6.1.1]
112614524  ADCY9; adenylate cyclase type 9 [KO:K08049] [EC:4.6.1.1]
112608183  PRKACG; cAMP-dependent protein kinase catalytic subunit gamma [KO:K04345] [EC:2.7.11.11]
112618864  PRKACB; cAMP-dependent protein kinase catalytic subunit beta isoform X1 [KO:K04345] [EC:2.7.11.11]
112612552  PRKACA; cAMP-dependent protein kinase catalytic subunit alpha isoform X1 [KO:K04345] [EC:2.7.11.11]
112636017  CREB1; cyclic AMP-responsive element-binding protein 1 isoform X1 [KO:K05870]
112636593  ATF2; cyclic AMP-dependent transcription factor ATF-2 isoform X1 [KO:K04450]
112632664  ATF4; cyclic AMP-dependent transcription factor ATF-4 isoform X1 [KO:K04374]
112620604  CREB3L2; cyclic AMP-responsive element-binding protein 3-like protein 2 [KO:K09048]
112613040  CREB3L3; cyclic AMP-responsive element-binding protein 3-like protein 3 isoform X1 [KO:K09048]
112607019  CREB3L1; cyclic AMP-responsive element-binding protein 3-like protein 1 [KO:K09048]
112636418  CREB3L4; cyclic AMP-responsive element-binding protein 3-like protein 4 isoform X1 [KO:K09048]
112608313  CREB3; cyclic AMP-responsive element-binding protein 3 [KO:K09048]
112621312  CREB5; cyclic AMP-responsive element-binding protein 5 isoform X1 [KO:K09047]
112622249  ATF6B; cyclic AMP-dependent transcription factor ATF-6 beta isoform X1 [KO:K09049]
112606904  MEN1; menin [KO:K14970]
112630641  ASH2L; set1/Ash2 histone methyltransferase complex subunit ASH2 isoform X1 [KO:K14964]
112609655  RBBP5; retinoblastoma-binding protein 5 isoform X1 [KO:K14961]
112608335  WDR5; WD repeat-containing protein 5 isoform X1 [KO:K14963]
112618257  WDR5B; WD repeat-containing protein 5B [KO:K14963]
112606639  KMT2A; histone-lysine N-methyltransferase 2A isoform X1 [KO:K09186] [EC:2.1.1.354]
112634043  KMT2D; histone-lysine N-methyltransferase 2D [KO:K09187] [EC:2.1.1.354]
112626379  CDKN2C; cyclin-dependent kinase 4 inhibitor C [KO:K06622]
112607789  CDKN2B; cyclin-dependent kinase 4 inhibitor B isoform X1 [KO:K04685]
112607787  cyclin-dependent kinase inhibitor 2A isoform X1 [KO:K06621]
112607790  tumor suppressor ARF-like [KO:K06621]
112634055  CDK4; cyclin-dependent kinase 4 isoform X1 [KO:K02089] [EC:2.7.11.22]
112620347  CDK6; cyclin-dependent kinase 6 [KO:K02091] [EC:2.7.11.22]
112605640  CCND1; G1/S-specific cyclin-D1 isoform X1 [KO:K04503]
112610754  RB1; retinoblastoma-associated protein [KO:K06618]
112632890  E2F1; transcription factor E2F1 [KO:K17454]
112629771  E2F2; transcription factor E2F2 [KO:K09389]
112623737  E2F3; transcription factor E2F3 isoform X1 [KO:K06620]
112609305  RASD1; dexamethasone-induced Ras-related protein 1 isoform X1 [KO:K07843]
112620903  GNAI1; guanine nucleotide-binding protein G(i) subunit alpha-1 isoform X1 [KO:K04630]
112625820  GNAI3; guanine nucleotide-binding protein G(k) subunit alpha [KO:K04630]
112618989  GNAI2; guanine nucleotide-binding protein G(i) subunit alpha-2 isoform X1 [KO:K04630]
112621224  AHR; aryl hydrocarbon receptor [KO:K09093]
112606405  AIP; AH receptor-interacting protein isoform X1 [KO:K17767]
112609244  AIPL1; aryl-hydrocarbon-interacting protein-like 1 isoform X1 [KO:K17767]
112620303  ARNT; aryl hydrocarbon receptor nuclear translocator isoform X1 [KO:K09097]
112634261  CDKN1B; cyclin-dependent kinase inhibitor 1B isoform X1 [KO:K06624]
112633979  CDK2; cyclin-dependent kinase 2 isoform X1 [KO:K02206] [EC:2.7.11.22]
112629797  CCNE2; G1/S-specific cyclin-E2 isoform X1 [KO:K06626]
112612586  CCNE1; G1/S-specific cyclin-E1 isoform X1 [KO:K06626]
112623750  CDKN1A; cyclin-dependent kinase inhibitor 1 isoform X1 [KO:K06625]
112634000  CACNA1C; voltage-dependent L-type calcium channel subunit alpha-1C isoform X1 [KO:K04850]
112618467  CACNA1D; voltage-dependent L-type calcium channel subunit alpha-1D isoform X1 [KO:K04851]
112614995  CACNA1F; voltage-dependent L-type calcium channel subunit alpha-1F [KO:K04853]
112625837  CACNA1S; voltage-dependent L-type calcium channel subunit alpha-1S [KO:K04857]
112621751  CAMK2B; calcium/calmodulin-dependent protein kinase type II subunit beta isoform X1 [KO:K04515] [EC:2.7.11.17]
112631191  CAMK2G; calcium/calmodulin-dependent protein kinase type II subunit gamma isoform X1 [KO:K04515] [EC:2.7.11.17]
112624412  CAMK2D; calcium/calmodulin-dependent protein kinase type II subunit delta isoform X1 [KO:K04515] [EC:2.7.11.17]
112625819  CAMK2A; calcium/calmodulin-dependent protein kinase type II subunit alpha isoform X1 [KO:K04515] [EC:2.7.11.17]
112626061  RAP1A; ras-related protein Rap-1A isoform X1 [KO:K04353]
112635460  RAP1B; ras-related protein Rap-1b isoform X1 [KO:K07836]
112620354  BRAF; serine/threonine-protein kinase B-raf [KO:K04365] [EC:2.7.11.1]
112627624  MAP2K1; dual specificity mitogen-activated protein kinase kinase 1 isoform X1 [KO:K04368] [EC:2.7.12.2]
112612394  MAP2K2; LOW QUALITY PROTEIN: dual specificity mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]
112614214  MAPK3; mitogen-activated protein kinase 3 isoform X1 [KO:K04371] [EC:2.7.11.24]
112632792  MAPK1; mitogen-activated protein kinase 1 isoform X1 [KO:K04371] [EC:2.7.11.24]
112634399  NR4A1; nuclear receptor subfamily 4 group A member 1 isoform X1 [KO:K04465]
112620091  EGFR; epidermal growth factor receptor isoform X1 [KO:K04361] [EC:2.7.10.1]
112627627  USP8; ubiquitin carboxyl-terminal hydrolase 8 isoform X1 [KO:K11839] [EC:3.4.19.12]
112605009  POMC; pro-opiomelanocortin [KO:K05228]
112611601  MC2R; adrenocorticotropic hormone receptor [KO:K04200]
112621427  MRAP; melanocortin-2 receptor accessory protein isoform X1 [KO:K22398]
112628817  PDE8A; high affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A isoform X1 [KO:K18437] [EC:3.1.4.53]
112625864  PDE8B; high affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8B isoform X1 [KO:K18437] [EC:3.1.4.53]
112636628  PDE11A; dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A isoform X1 [KO:K13298] [EC:3.1.4.17 3.1.4.35]
112608088  NR5A1; steroidogenic factor 1 [KO:K08560]
112634626  SP1; transcription factor Sp1 isoform X1 [KO:K04684]
112620982  PBX1; pre-B-cell leukemia transcription factor 1 isoform X1 [KO:K09355]
112630213  cytochrome P450 11B1, mitochondrial-like [KO:K00497] [EC:1.14.15.4]
112630247  cytochrome P450 11B1, mitochondrial isoform X1 [KO:K00497] [EC:1.14.15.4]
112630974  steroid 17-alpha-hydroxylase/17,20 lyase [KO:K00512] [EC:1.14.14.19 1.14.14.32]
112630644  STAR; steroidogenic acute regulatory protein, mitochondrial [KO:K16931]
112619286  NCEH1; neutral cholesterol ester hydrolase 1 isoform X1 [KO:K14349] [EC:3.1.1.-]
112614561  ARMC5; armadillo repeat-containing protein 5 isoform X1 [KO:K22499]
112628065  AGT; angiotensinogen isoform X1 [KO:K09821]
112618692  AGTR1; type-1 angiotensin II receptor isoform X1 [KO:K04166]
112607858  GNAQ; guanine nucleotide-binding protein G(q) subunit alpha [KO:K04634]
112612879  GNA11; guanine nucleotide-binding protein subunit alpha-11 isoform X1 [KO:K04635]
112607332  PLCB3; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-3 isoform X1 [KO:K05858] [EC:3.1.4.11]
112633067  PLCB1; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1 isoform X1 [KO:K05858] [EC:3.1.4.11]
112633206  PLCB4; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-4 isoform X1 [KO:K05858] [EC:3.1.4.11]
112627584  PLCB2; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2 isoform X1 [KO:K05858] [EC:3.1.4.11]
112618470  ITPR1; inositol 1,4,5-trisphosphate receptor type 1 [KO:K04958]
112634518  ITPR2; inositol 1,4,5-trisphosphate receptor type 2 [KO:K04959]
112622816  ITPR3; inositol 1,4,5-trisphosphate receptor type 3 [KO:K04960]
112612170  KCNK2; potassium channel subfamily K member 2 isoform X1 [KO:K04913]
112608876  CACNA1G; voltage-dependent T-type calcium channel subunit alpha-1G isoform X1 [KO:K04854]
112614052  CACNA1H; voltage-dependent T-type calcium channel subunit alpha-1H isoform X1 [KO:K04855]
112632965  CACNA1I; voltage-dependent T-type calcium channel subunit alpha-1I [KO:K04856]
112634597  ORAI1; calcium release-activated calcium channel protein 1 isoform X1 [KO:K16056]
112606619  KCNA4; potassium voltage-gated channel subfamily A member 4 [KO:K04877]
112604755  KCNK3; potassium channel subfamily K member 3 [KO:K04914]
112612219  LDLR; low-density lipoprotein receptor isoform X1 [KO:K12473]
112634448  SCARB1; scavenger receptor class B member 1 isoform X1 [KO:K13885]
112627656  cholesterol side-chain cleavage enzyme, mitochondrial isoform X1 [KO:K00498] [EC:1.14.15.6]
112624233  3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1 [KO:K00070] [EC:1.1.1.145 5.3.3.1]
112634262  HSD3B2; 3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 2 isoform X1 [KO:K00070] [EC:1.1.1.145 5.3.3.1]
112622250  steroid 21-hydroxylase isoform X1 [KO:K00513] [EC:1.14.14.16]
112628430  FH; fumarate hydratase, mitochondrial [KO:K01679] [EC:4.2.1.2]
112635320  WNT1; proto-oncogene Wnt-1 [KO:K03209]
112620705  WNT2; protein Wnt-2 [KO:K00182]
112617224  WNT2B; protein Wnt-2b isoform X1 [KO:K00182]
112609646  WNT3; proto-oncogene Wnt-3 [KO:K00312]
112616995  protein Wnt-3a [KO:K00312]
112617012  protein Wnt-3a [KO:K00312]
112630880  WNT4; protein Wnt-4 [KO:K00408]
112635051  WNT5B; protein Wnt-5b isoform X1 [KO:K00444]
112619680  WNT5A; protein Wnt-5a isoform X1 [KO:K00444]
112636290  WNT6; protein Wnt-6 [KO:K00445]
112633481  WNT7B; protein Wnt-7b isoform X1 [KO:K00572]
112619206  WNT7A; protein Wnt-7a [KO:K00572]
112631846  WNT8B; protein Wnt-8b [KO:K00714]
112626720  WNT8A; protein Wnt-8a [KO:K00714]
112606648  WNT9A; protein Wnt-9a [KO:K01064]
112609925  WNT9B; protein Wnt-9b [KO:K01064]
112635335  WNT10B; protein Wnt-10b [KO:K01357]
112636269  WNT10A; protein Wnt-10a [KO:K01357]
112606460  WNT11; protein Wnt-11 [KO:K01384]
112620719  WNT16; protein Wnt-16 isoform X1 [KO:K01558]
112621499  FZD1; frizzled-1 [KO:K02432]
112636605  FZD7; frizzled-7 [KO:K02432]
112610403  FZD2; frizzled-2 [KO:K02235]
112630226  FZD3; frizzled-3 [KO:K02329]
112607389  FZD4; frizzled-4 [KO:K02354]
112636167  FZD5; frizzled-5 [KO:K02375]
112631803  FZD8; frizzled-8 [KO:K02375]
112630429  FZD6; frizzled-6 isoform X1 [KO:K02376]
112635061  FZD10; frizzled-10 [KO:K02842]
112620236  FZD9; frizzled-9 [KO:K02842]
112608975  DVL2; segment polarity protein dishevelled homolog DVL-2 isoform X1 [KO:K02353]
112617036  segment polarity protein dishevelled homolog DVL-1-like [KO:K02353]
112617045  segment polarity protein dishevelled homolog DVL-1-like [KO:K02353]
112618281  DVL3; segment polarity protein dishevelled homolog DVL-3 isoform X1 [KO:K02353]
112618595  GSK3B; glycogen synthase kinase-3 beta isoform X1 [KO:K03083] [EC:2.7.11.26]
112613775  AXIN1; axin-1 isoform X1 [KO:K02157]
112609478  AXIN2; axin-2 isoform X1 [KO:K04385]
112618943  CTNNB1; catenin beta-1 isoform X1 [KO:K02105]
112612730  APC2; adenomatous polyposis coli protein 2 [KO:K02085]
112625954  APC; adenomatous polyposis coli protein isoform X1 [KO:K02085]
112626303  TCF7; LOW QUALITY PROTEIN: transcription factor 7 [KO:K02620]
112604528  TCF7L1; transcription factor 7-like 1 [KO:K04490]
112631247  TCF7L2; transcription factor 7-like 2 isoform X1 [KO:K04491]
112624710  LEF1; lymphoid enhancer-binding factor 1 isoform X1 [KO:K04492]
Compound
C00020  AMP
C00076  Calcium cation
C00187  Cholesterol
C00238  Potassium cation
C00410  Progesterone
C00575  3',5'-Cyclic AMP
C00735  Cortisol
C01176  17alpha-Hydroxyprogesterone
C01245  D-myo-Inositol 1,4,5-trisphosphate
C01953  Pregnenolone
C05138  17alpha-Hydroxypregnenolone
C05488  11-Deoxycortisol
C07557  2,3,7,8-Tetrachlorodibenzodioxin
Reference
  Authors
Lacroix A, Feelders RA, Stratakis CA, Nieman LK
  Title
Cushing's syndrome.
  Journal
Lancet 386:913-27 (2015)
DOI:10.1016/S0140-6736(14)61375-1
Reference
  Authors
Xiong Q, Ge W
  Title
Gene mutations in Cushing's disease.
  Journal
Biomed Rep 5:277-282 (2016)
DOI:10.3892/br.2016.729
Reference
  Authors
Fukuoka H, Takahashi Y
  Title
The role of genetic and epigenetic changes in pituitary tumorigenesis.
  Journal
Neurol Med Chir (Tokyo) 54 Suppl 3:943-57 (2014)
DOI:10.2176/nmc.suppl.2014-3
Reference
  Authors
Quereda V, Malumbres M
  Title
Cell cycle control of pituitary development and disease.
  Journal
J Mol Endocrinol 42:75-86 (2009)
DOI:10.1677/JME-08-0146
Reference
  Authors
Caimari F, Korbonits M
  Title
Novel Genetic Causes of Pituitary Adenomas.
  Journal
Clin Cancer Res 22:5030-5042 (2016)
DOI:10.1158/1078-0432.CCR-16-0452
Reference
  Authors
Lecoq AL, Kamenicky P, Guiochon-Mantel A, Chanson P
  Title
Genetic mutations in sporadic pituitary adenomas--what to screen for?
  Journal
Nat Rev Endocrinol 11:43-54 (2015)
DOI:10.1038/nrendo.2014.181
Reference
  Authors
Hannah-Shmouni F, Faucz FR, Stratakis CA
  Title
Alterations of Phosphodiesterases in Adrenocortical Tumors.
  Journal
Front Endocrinol (Lausanne) 7:111 (2016)
DOI:10.3389/fendo.2016.00111
Reference
  Authors
Melmed S
  Title
Pathogenesis of pituitary tumors.
  Journal
Nat Rev Endocrinol 7:257-66 (2011)
DOI:10.1038/nrendo.2011.40
Reference
  Authors
Daly AF, Tichomirowa MA, Beckers A
  Title
Genetic, molecular and clinical features of familial isolated pituitary adenomas.
  Journal
Horm Res 71 Suppl 2:116-22 (2009)
DOI:10.1159/000192448
Reference
  Authors
Albani A, Theodoropoulou M, Reincke M
  Title
Genetics of Cushing's disease.
  Journal
Clin Endocrinol (Oxf) 88:3-12 (2018)
DOI:10.1111/cen.13457
Reference
  Authors
Duan K, Hernandez KG, Mete O
  Title
Clinicopathological correlates of adrenal Cushing's syndrome.
  Journal
Postgrad Med J 91:331-42 (2015)
DOI:10.1136/postgradmedj-2014-202612rep
Reference
  Authors
Drougat L, Espiard S, Bertherat J
  Title
Genetics of primary bilateral macronodular adrenal hyperplasia: a model for early diagnosis of Cushing's syndrome?
  Journal
Eur J Endocrinol 173:M121-31 (2015)
DOI:10.1530/EJE-15-0532
Reference
  Authors
Stratakis CA, Boikos SA
  Title
Genetics of adrenal tumors associated with Cushing's syndrome: a new classification for bilateral adrenocortical hyperplasias.
  Journal
Nat Clin Pract Endocrinol Metab 3:748-57 (2007)
DOI:10.1038/ncpendmet0648
Reference
  Authors
Refojo D, Holsboer F
  Title
CRH signaling. Molecular specificity for drug targeting in the CNS.
  Journal
Ann N Y Acad Sci 1179:106-19 (2009)
DOI:10.1111/j.1749-6632.2009.04983.x
Reference
  Authors
Kovalovsky D, Refojo D, Liberman AC, Hochbaum D, Pereda MP, Coso OA, Stalla GK, Holsboer F, Arzt E
  Title
Activation and induction of NUR77/NURR1 in corticotrophs by CRH/cAMP: involvement of calcium, protein kinase A, and MAPK pathways.
  Journal
Mol Endocrinol 16:1638-51 (2002)
DOI:10.1210/mend.16.7.0863
Reference
  Authors
Lacroix A, Baldacchino V, Bourdeau I, Hamet P, Tremblay J
  Title
Cushing's syndrome variants secondary to aberrant hormone receptors.
  Journal
Trends Endocrinol Metab 15:375-82 (2004)
DOI:10.1016/j.tem.2004.08.007
Reference
  Authors
Reincke M, Sbiera S, Hayakawa A, Theodoropoulou M, Osswald A, Beuschlein F, Meitinger T, Mizuno-Yamasaki E, Kawaguchi K, Saeki Y, Tanaka K, Wieland T, Graf E, Saeger W, Ronchi CL, Allolio B, Buchfelder M, Strom TM, Fassnacht M, Komada M
  Title
Mutations in the deubiquitinase gene USP8 cause Cushing's disease.
  Journal
Nat Genet 47:31-8 (2015)
DOI:10.1038/ng.3166
Reference
  Authors
Kaiser UB
  Title
Cushing's disease: towards precision medicine.
  Journal
Cell Res 25:649-50 (2015)
DOI:10.1038/cr.2015.53
Reference
  Authors
Uzilov AV, Cheesman KC, Fink MY, Newman LC, Pandya C, Lalazar Y, Hefti M, Fowkes M, Deikus G, Lau CY, Moe AS, Kinoshita Y, Kasai Y, Zweig M, Gupta A, Starcevic D, Mahajan M, Schadt EE, Post KD, Donovan MJ, Sebra R, Chen R, Geer EB
  Title
Identification of a novel RASD1 somatic mutation in a USP8-mutated corticotroph adenoma.
  Journal
Cold Spring Harb Mol Case Stud 3:a001602 (2017)
DOI:10.1101/mcs.a001602
Reference
  Authors
Huang C, Shi Y, Zhao Y
  Title
USP8 mutation in Cushing's disease.
  Journal
Oncotarget 6:18240-1 (2015)
DOI:10.18632/oncotarget.4856
Reference
  Authors
Theodoropoulou M, Reincke M, Fassnacht M, Komada M
  Title
Decoding the genetic basis of Cushing's disease: USP8 in the spotlight.
  Journal
Eur J Endocrinol 173:M73-83 (2015)
DOI:10.1530/EJE-15-0320
Reference
  Authors
Yu L, Zhang J, Guo X, Chen X, He Z, He Q
  Title
ARMC5 mutations in familial and sporadic primary bilateral macronodular adrenal hyperplasia.
  Journal
PLoS One 13:e0191602 (2018)
DOI:10.1371/journal.pone.0191602
Reference
  Authors
Wu X, Hua X
  Title
Menin, histone h3 methyltransferases, and regulation of cell proliferation: current knowledge and perspective.
  Journal
Curr Mol Med 8:805-15 (2008)
DOI:10.2174/156652408786733702
Reference
  Authors
Ozfirat Z, Korbonits M
  Title
AIP gene and familial isolated pituitary adenomas.
  Journal
Mol Cell Endocrinol 326:71-9 (2010)
DOI:10.1016/j.mce.2010.05.001
Related
pathway
tge00020  Citrate cycle (TCA cycle)
tge00140  Steroid hormone biosynthesis
tge04020  Calcium signaling pathway
tge04024  cAMP signaling pathway
tge04110  Cell cycle
tge04310  Wnt signaling pathway
tge04927  Cortisol synthesis and secretion
tge04960  Aldosterone-regulated sodium reabsorption
KO pathway
ko04934   
LinkDB

DBGET integrated database retrieval system